The effect of Greek herbal tea consumption on thyroid cancer: A case-control study

European Journal of Public Health

Volumn 25, Issue 6, 2015, Pages 1001-1005

  Riza, Elena ^a   Linos, Athena ^a,b   Petralias, Athanassios ^b,c   De Martinis, Luca ^d   Duntas, Leonidas ^e   Linos, Dimitrios ^a,f  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Institute of Preventive Medicine Environmental and Occupational HealthProlepsis   (Greece)

^c ATHENS UNIVERSITY OF ECONOMICS AND BUSINESS   (Greece)

^d IRCCS   (Italy)

^e UNIVERSITY OF ATHENS   (Greece)

^f HYGEIA HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHAMOMILE; HERBAL TEA;

ADULT; CASE CONTROL STUDY; EPIDEMIOLOGY; FEMALE; GREECE; HERBAL TEA; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; SALVIA OFFICINALIS; THYROID DISEASES; THYROID NEOPLASMS; TIME FACTOR;

ADULT; CASE-CONTROL STUDIES; CHAMOMILE; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SALVIA OFFICINALIS; TEAS, HERBAL; THYROID DISEASES; THYROID NEOPLASMS; TIME FACTORS;

EID: 84943616281     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckv063     Document Type: Article

References (33)

1. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 1997;37:693-704.
2. Tsubono Y, Nishino Y, Komatsu S, et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med 2001;344:632-6.
3. Osada K, Takahashi M, Hoshina S, et al. Teacatechins inhibit chole sterol oxidation accompanying oxidation of low density lipoprotein in vitro. Comp Biochem Physiol Part C Toxicol Pharmacol 2001;128:153-64.
4. Riegsecker S, Wiczynski D, Kaplan MJ, Ahmed S. Potent ial benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis. Life Sci 2013;93:307-12.
5. Sudano Roccaro A, Blanco AR, Giuliano F, et al. Epigallocatechin-gallate enhances the activity of tetracycline in staphylococci by inhibiting its efflux from bacterial cells. Antimicrob Agents Chemother 2004;48:1968-73.
6. Katiyar SK, Raman C. Gree n tea: a new option for the prevention or control of osteoarthritis. Arthritis Res Ther 2011;13:121.
7. Ide K, Yamada H, Matsushita K, et al. Effects of green tea gargling on the prevention of inf luenza infection in high school students: a randomized controlled study. PLoS One 2014;9:e96373.
8. Shimizu M, Shirakami Y, Sakai H, et al. Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem Biol Interact 2010;185:247-52.
9. Grelle G, Otto A, Lorenz M, et al. Black tea theaflavins inhibit formation of toxic amyloid-b and a-synuclein fibrils. Biochemistry 2011;50:10624-36.
10. Hirsova P, Kolouchov a G, Dolezelova E, et al. Epigallocatechin gallate enhances biliary cholesterol secretion in healthy rats and lowers plasma and liver cholesterol in ethinylestradiol-treated rats. Eur J Pharmacol 2012;691:38-45.
11. Lambert JD. Does tea prevent cancer Evidence from laboratory and human intervention studies. Am J Clin Nutr 2013;98:1667S-75.
12. Arab L, Khan F, Lam H. Tea consumption and cardiovascular disease risk. Am J Clin Nutr 2013;98:1651S-59.
13. Hininger-Favier I, Benaraba R, Coves S, et al. Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal mode of ins ulin resistance, the fructose-fed rat. J Am Coll Nutr 2009;28:355-61.
14. Huxley R, Lee CM, Barzi F, et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabete s mellitus: a systematic review with metaanalysis. Arch Intern Med 2009;169:2053-63.
15. Chandra AK, De N. Catechin induced modulation in the activities of thyroid hormone synthesizing enzymes leading to hypothyroidism. Mol Cell Biochem 2013;374:37-48.
16. Yang G, Shu XO, Li H, et al. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 2007;16:1219-23.
17. Mineva ND,Paulson KE,Naber SP,et al. Epigallocatechin-3-gallate inhibits stemlike inflammatory breast cancer cells PLoS One 2013 8: e73464.
18. Gu Q, Hu C, Chen Q, et al. Tea polyphenols prevent lung from preneoplastic lesions and effect p53 and bcl-2 gene expression in rat lung tissues. Int J Clin Exp Pathol 2013;6:1523-31.
19. Jian L, Xie LP, Lee AH, et al. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 2004;108:130-5.
20. Hou IC, Amarnani S, Chong MT, et al. Green tea and the risk of gastric cancer: epidemiological evidence. World J Gastroenterol 2013;19:3713-22.
21. Lee AH, Su D, Pasalich M, et al. Tea consumption reduces ovarian cancer risk. Cancer Epidemiol 2013;37:54-9.
22. Markaki I, Linos D, Linos A. The influence of dietary patterns on the development of thyroid cancer. Eur J Cancer 2003;39:1912-9.
23. Chacko SM, Thambi PT, Kuttan R, et al. Beneficial effects of green tea: a literature review. Chin Med 2010;5:13.
24. Mack WJ, Preston-Martin S, Bernstein L, et al. Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol 2002;12:395-401.
25. Mack WJ, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control 2003;14:773-85.
26. Michikawa T, Inoue M, Shimazu T, et al. Green tea and coffee consumption and its association with thyroid cancer risk: a population-based cohort study in Japan. Cancer Causes Control 2011;22:985-93.
27. Kuruto-Niwa R, Inoue S, Ogawa S, et al. Effects of tea catechins on the EREregulated estrogenic activity. J Agric Food Chem 2000;48:6355-61.
28. Rosen JE, Gardiner P, Saper RB, et al. Complementary and alternative medicine use among patients with thyroid cancer. Thyroid 2013;23:1238-46.
29. Dou QP. Molecular mechanisms of green tea polyphenols. Nutr Cancer 2009;61:827-35.
30. Ohye H, Sugawara M. Dual oxidase, hydrogen peroxide and thyroid diseases. Exp Biol Med (Maywood) 2010;235:424-33.
31. De Amicis F, Perri A, Vizza D, et al. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroidcarcinoma cell lines. J Cell Physiol 2013;228:2054-62.
32. Lim YC, Cha YY. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroidcarcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex. J Surg Oncol 2011;104:776-80.
33. Mazumdar M, A dhikary A, Chakraborty S, et al. Targeting RET to induce medullary thyroid cancer cell apoptosis: an antagonistic interplay between PI3K/Akt and p38MAPK/caspase-8 pathways. Apoptosis 2013;18:589-604.